๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Targets for sepsis therapies: Tumor necrosis factor versus interleukin-1

โœ Scribed by Deborah A Russell; Robert C Thompson


Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
878 KB
Volume
4
Category
Article
ISSN
0958-1669

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Rheumatoid arthritis therapy after tumor
โœ Kurt Redlich; Georg Schett; Gรผnter Steiner; Silvia Hayer; Erwin F. Wagner; Josef ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 711 KB

With concomitant methotrexate. โ€  Pegylated recombinant methionyl human soluble tumor necrosis factor type I.

Interleukin-18 induces production of pro
โœ Mihaiโ€„G. Netea; Bartโ€„Jan Kullberg; Ineke Verschueren; Josโ€„W.โ€„M.โ€„Vanโ€„der Meer ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB ๐Ÿ‘ 2 views

Interleukin-18 (IL-18) is not only a co-stimulus for the induction of interferon-gamma but also has direct proinflammatory effects by inducing tumor necrosis factor-alpha (TNF-alpha), IL-1, IL-8 and IL-6. However, the cascade of events leading to induction of cytokines by IL-18 is unclear. The aim o